SHKK(SH:600272)2016-04-28 16:00Financial Performance - Net profit attributable to shareholders rose by 10.05% to CNY 4,400,280.99 year-on-year[5] - Operating revenue increased by 2.13% to CNY 254,717,619.57 compared to the same period last year[5] - Total revenue for the first quarter was CNY 254,717,619.57, an increase from CNY 249,401,660.17 in the previous period, representing a growth of approximately 1.3%[23] - Net profit for the first quarter reached CNY 4,305,616.83, compared to CNY 3,980,511.57 in the same period last year, reflecting a growth of approximately 8.2%[23] - The operating profit for the first quarter was CNY 5,136,367.40, compared to CNY 4,628,914.05 in the previous year, indicating an increase of about 10.9%[23] - There are no significant changes expected in net profit compared to the same period last year, indicating stability in financial performance[14] Assets and Liabilities - Total assets increased by 0.60% to CNY 1,037,732,233.06 compared to the end of the previous year[5] - As of March 31, 2016, the total assets of Shanghai Kaikai Industrial Co., Ltd. amounted to CNY 1,037,732,233.06, compared to CNY 1,031,549,580.68 at the beginning of the year, reflecting a slight increase[16] - The company's current assets totaled CNY 376,821,204.56, down from CNY 381,340,573.25 at the beginning of the year, indicating a decrease of approximately 1.36%[16] - Total liabilities decreased from CNY 513,443,692.52 to CNY 504,536,244.88, a decline of about 1.77%[17] - Total liabilities increased to CNY 202,509,197.30 from CNY 193,364,530.43, representing a rise of approximately 4.9%[20] - The company's equity increased from CNY 518,105,888.16 to CNY 533,195,988.18, reflecting a growth of approximately 2.93%[17] Cash Flow - Cash flow from operating activities showed a significant decline of 379.97%, resulting in a net outflow of CNY 8,851,006.81[5] - Cash and cash equivalents decreased from CNY 131,847,107.88 to CNY 123,368,336.15, a decline of about 6.73%[16] - Cash and cash equivalents at the end of Q1 2016 were CNY 123,368,336.15, down from CNY 152,399,708.42 at the end of Q1 2015, a decrease of about 19.1%[29] - Operating cash inflow for Q1 2016 was CNY 8,573,417.93, down 13.2% from CNY 9,879,229.16 in the previous period[31] - Net cash flow from operating activities increased to CNY 2,682,492.38, a 36.7% rise compared to CNY 1,961,775.40 in the same period last year[31] - The net increase in cash and cash equivalents for the period was CNY 3,208,865.86, down 92.7% from CNY 44,137,665.81 in the previous period[31] Shareholder Information - The number of shareholders reached 31,498, with the largest shareholder holding 26.51% of the shares[8] - Basic and diluted earnings per share remained stable at CNY 0.02 for both periods[24] - The company’s earnings per share remained at -0.01 CNY for both basic and diluted earnings per share, unchanged from the previous year[26] Other Financial Metrics - The weighted average return on equity decreased by 0.16 percentage points to 0.81%[5] - Non-recurring gains and losses totaled CNY 2,281,094.71, primarily from government subsidies and other income[7] - The company reported a decrease in financial expenses due to a decline in the USD exchange rate, impacting receivables[11] - Investment income from joint ventures decreased, reflecting a reduction in losses from Shanghai Jing'an Pharmaceutical Co., Ltd.[12] - The company incurred management expenses of CNY 4,412,510.28, slightly higher than CNY 4,210,674.35 in Q1 2015, reflecting an increase of approximately 4.8%[26] - Other comprehensive income after tax for the period was CNY 10,784,483.19, down from CNY 29,936,533.35 in the previous period, a decrease of approximately 64.0%[24]